SKIN - NASDAQ
The Beauty Health Company
$0.63
-9.8%The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
At a Glance
Live Snapshotskin
Cost of Revenue
Last Annual Value
104.40M
3-Year CAGR
-4%
5-Year CAGR
15%
10-Year CAGR
10%
The Beauty Health Company Competitors Analysis of Cost of Revenue
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
The Beauty Health Company NASDAQ:SKIN | 104.40M | -24.5% | 5.1% | N/A | |
 FitLife Brands, Inc. NASDAQ:FTLF | 50.01M | 16.9% | 26.5% | 12.6% | |
 Solesence, Inc. Common Stock NASDAQ:SLSN | 46.00M | 16.0% | 17.2% | N/A | |
 Chegg, Inc. NYSE:CHGG | 150.05M | -12.8% | -10.1% | 2.3% | |
 Ispire Technology Inc. NASDAQ:ISPR | 104.84M | 3.4% | 14.6% | N/A | |
 European Wax Center, Inc. NASDAQ:EWCZ | 53.83M | -4.9% | 2.8% | N/A | |
 Acme United Corporation AMEX:ACU | 119.13M | -0.0% | 0.3% | 4.2% | |
1.66B | 12.6% | N/A | N/A | ||
 Zevia PBC NYSE:ZVIA | 84.71M | -2.6% | 2.7% | N/A | |
 Skillsoft Corp. NYSE:SKIL | 134.64M | -4.0% | N/A | N/A |
The Beauty Health Company Fair Value Envelope
Related Guides
Continue your SKIN research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.